Migalastat 150 mg every other day achieves bioequivalent exposures in adolescent and adult patients with Fabry disease

Authors
Category Primary study
JournalMolecular Genetics and Metabolism
Year 2021
This article has no abstract
Epistemonikos ID: e603d89a85c14c6021243a073a56e84b784713b2
First added on: Feb 12, 2025